Beyond Genetics: Exploring the Role of Epigenetic Alterations in Breast Cancer

Kirti S. Prabhu,Hana Q. Sadida,Shilpa Kuttikrishnan,Kulsoom Junejo,Ajaz A. Bhat,Shahab Uddin
DOI: https://doi.org/10.1016/j.prp.2024.155174
IF: 3.309
2024-01-28
Pathology - Research and Practice
Abstract:Breast cancer remains a major global health challenge. Its rising incidence is attributed to factors such as delayed diagnosis, the complexity of its subtypes, and increasing drug resistance, all contributing to less-than-ideal patient outcomes. Central to the progression of breast cancer are epigenetic aberrations, which significantly contribute to drug resistance and the emergence of cancer stem cell traits. These include alterations in DNA methylation, histone modifications, and the expression of non-coding RNAs. Understanding these epigenetic changes is crucial for developing advanced breast cancer management strategies despite their complexity. Investigating these epigenetic modifications offers the potential for novel diagnostic markers, more accurate prognostic indicators, and the identification of reliable predictors of treatment response. This could lead to the development of new targeted therapies. However, this requires sustained, focused research efforts to navigate the challenges of understanding breast cancer carcinogenesis and its epigenetic underpinnings. A deeper understanding of epigenetic mechanisms in breast cancer can revolutionize personalized medicine. This could lead to significant improvements in patient care, including early detection, precise disease stratification, and more effective treatment options.
pathology
What problem does this paper attempt to address?